Invasive Haemophilus influenzae Infection in Patients With Cancer.

Author: GreeneJohn N, NanjappaSowmya, PabbathiSmitha, SinghVivek

Paper Details 
Original Abstract of the Article :
A major cause of morbidity and mortality in patients with cancer is infection. Since the introduction of the Haemophilus influenzae type b (Hib) vaccine in the United States in the 1990s, invasive H influenzae infection has become less common. We report on 5 patients with cancer and invasive H influ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1177/107327481702400111

データ提供:米国国立医学図書館(NLM)

Invasive Haemophilus influenzae Infection: A Journey Through the Desert of Immunity

Haemophilus influenzae is a bacteria that can cause a variety of infections, ranging from mild ear infections to serious invasive diseases. This study examines cases of invasive H. influenzae infection in patients with cancer, highlighting the challenges of managing these infections in immunocompromised individuals. The researchers analyzed a series of case reports and conducted a literature review to identify the clinical features and risk factors associated with invasive H. influenzae infection in this patient population.

A Shifting Landscape of Infection: The Impact of Vaccination

The study found that invasive H. influenzae infection is less common in patients with cancer since the introduction of the Hib vaccine. However, nontypable H. influenzae (NTHi) remains a significant threat, particularly in immunocompromised individuals. This finding underscores the importance of vaccination and highlights the need for vigilance in monitoring for infection in those with weakened immune systems.

Navigating the Desert of Immunity: A Call for Prevention

This study emphasizes the importance of preventive measures in reducing the risk of invasive H. influenzae infection, particularly in patients with cancer. Vaccination, adherence to infection control measures, and prompt treatment of any signs of infection are crucial strategies for managing this potential threat. The study also highlights the need for awareness among healthcare providers about the changing epidemiology of H. influenzae infection and the importance of early identification and treatment to minimize complications.

Dr.Camel's Conclusion

This research underscores the importance of understanding the shifting sands of infectious diseases. While vaccines have dramatically reduced the incidence of invasive H. influenzae infection, we must remain vigilant, particularly in vulnerable populations. By embracing preventive measures and staying abreast of emerging trends, we can continue to navigate this challenging landscape and protect those at risk.

Date :
  1. Date Completed 2017-02-21
  2. Date Revised 2017-12-21
Further Info :

Pubmed ID

28178716

DOI: Digital Object Identifier

10.1177/107327481702400111

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.